Skip to Main ContentSkip to FooterSkip to Search
Main menu

Why Catalent for Emerging Biotech?

 

Successful new treatments are built on biopharmaceutical science and the art of building a successful new biotech able to bring them to patients.

Hiring the right talent and securing the right mix of clinical, development, and manufacturing partners is vital to hitting all the milestones along the way.

Through our broad capabilities and vast experience of working with hundreds of emerging biotechs, we will tailor solutions that accelerate your timelines, from pre-clinical and first-in-human studies to developing CMC strategies to seamlessly scaling for a successful launch.

Catalent can be your one development and manufacturing partner, helping to simplify and de-risk your program with integrated solutions, deepest development expertise, broadest portfolio of drug delivery technologies and manufacturing platforms across modalities.

Let’s accelerate together!

BUILDING BIOTECH

Advice and strategies to build a better company and launch a successful treatment.

BUILDING PRODUCTS

Proven solutions to help accelerate, simplify and de-risk the achievement of critical milestones.

BUILDING PARTNERSHIPS WITH
BIOTECH CONSULTANTS

At Catalent we recognize and support the consultant’s role in biotech. Helping our partners to stay in tune with advancements, we are here to assist with strong scientific advice from industry experts to help overcome the biggest challenges. View our resources for developing partners.

BIOTECH CONSULTANTS

View our resources for developing partners.

Found 44 results in Better Biotech

How Working with a Consultant Can Help Your Biotech Business
The Next 5 Years in Emerging Biotech
A Q&A with Jim Spavins
FDA Approvals: Lessons Learned from COVID-19
How Does a Proven Development and Manufacturing Partner Help Early-Stage Biotech
Balancing Trajectory and Velocity: Encouraging Sustainable Growth in Biotech
Scaling the Emerging Biotech-Lessons from Leaders
Early Drug Development Strategies for Clinical Success
Comparator Drug Sourcing Solutions - Catalent’s Network Effects
Achieving Faster Timelines and Higher Titer in Antibody Expression When Combining GPEx® Cell Line Development Technology with the Beacon® Platform for Clonal Cell Line Selection